The Contractual Structure and Innovative Effects of Pharmaceutical-Biotechnology R&D Collaborations

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations

Abstract

This study investigates the conditions that shape the contractual structure of pharmaceutical-biotechnology R&D agreements and whether these collaborations have produced measurable impact on the overall R&D productivity of pharmaceutical companies. In one section, the effect of uncertainty due to the advances in technology on the structure of R&D contracts is discussed. Specifically, it is shown that newer technologies associated with higher uncertainty result in the choice of more hierarchical contract structures. In addition, the significance of R&D collaborations on the overall innovation process of pharmaceutical companies is evaluated. The results indicate that only some types of R&D alliances, signed in earlier stages of research, have a significant role in the patent production and drug discovery process.

Original languageAmerican English
Title of host publicationIssues in Entrepeneurship
Pages1-19
Number of pages19
DOIs
StatePublished - 2003

Publication series

NameAdvances in the Study of Entrepreneurship, Innovation, and Economic Growth
Volume14
ISSN (Print)1048-4736

EGS Disciplines

  • Economics

Fingerprint

Dive into the research topics of 'The Contractual Structure and Innovative Effects of Pharmaceutical-Biotechnology R&D Collaborations'. Together they form a unique fingerprint.

Cite this